From Policy to Impact: Accelerating Early Detection for Kidney-Heart Health
This session explores how to turn global policy commitments into action, improving early detection, and tackling the burden of CKD and interconnected heart conditions.
Kidney disease affects 1 in 10 adults worldwide – around 850 million people – and can lead to serious complications such as kidney and heart failure.[1] Yet 9 out of 10 don’t know they have it until it’s too late.[2]
Early detection can change this – protecting kidney and heart health, easing the burden on patients, their families, health systems, and economies alike. But how can we make this a reality for all?
Join Boehringer Ingelheim and Healthy.io for an interactive panel covering:
Insights and strategies to accelerate policy implementation following the recent WHO Kidney resolution and the UN High-Level Meeting on NCDs
Patient perspectives on chronic kidney disease (CKD) policy – ensuring decisions are person-centered and responsive to real-world needs
The importance of strong primary care that addresses cardiovascular, kidney, and metabolic health in an integrated way
Scalable, real-world solutions for early CKD detection and their potential to reduce health disparities with improved outcomes and lower costs
Speakers at the event will include:
Tamayo Marukawa, Former Parliamentary Vice-Minister of Health, Labour and Welfare of Japan & Former Chairperson of the Committee on Health, Welfare and Labour, House
Dhruv S. Kazi, MD, MSc, MS, Director, Cardiac Critical Care Unit, Beth Israel Deaconess Medical Center; Associate Director and Section Head for Health Economics, Richard A. and Susan F. Smith Center for Outcomes Research; Associate Professor of Medicine, Harvard Medical School; Associate Professor of Epidemiology, Harvard T.H Chan School of Public Health
Geoffrey G. Martin, CEO, Healthy.io
This event is sponsored by Boehringer Ingelheim.